Issues D&O underwriters need to know when evaluating a life science company – EVP at RT ProExec In this edition of the D&O & Life Sciences series, sponsored by RT Specialty Group, host Michael Garofalo, SVP in the National Life Science Practice at RT Specialty, welcomes Kevin LaCroix, an Executive Vice President at RT ProExec, a division of RT Specialty. The topic is D&O issues for life science companies. “Life Science companies are vulnerable to securities litigation,” … Read More
Carnegie Mellon CyLab study on cyber governance among major corporations. A Carnegie Mellon CyLab study, sponsored by RSA, a leading security, risk and compliance management solutions firm, Read More
